Get the Stockscreener App
85.85
0.85%
0.65
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Colgate Palmolive Co stock is traded at $85.85, with a volume of 3.27M.
It is up +0.85% in the last 24 hours and up +7.77% over the past month.
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.
See More
Previous Close:
$85.20
Open:
$85.05
24h Volume:
3.27M
Relative Volume:
0.49
Market Cap:
$69.24B
Revenue:
$20.10B
Net Income/Loss:
$3.04B
P/E Ratio:
24.05
EPS:
3.569
Net Cash Flow:
$3.44B
1W Performance:
+0.57%
1M Performance:
+7.77%
6M Performance:
-2.28%
1Y Performance:
-5.79%
1-Day Range:
$84.52
$85.98
1-Week Range:
$83.82
$86.89
52-Week Range:
$74.55
$100.18
Colgate Palmolive Co Stock (CL) Company Profile
Name
Colgate Palmolive Co
Sector
Industry
Phone
(212) 310-2000
Address
300 PARK AVE, NEW YORK, NY
Compare CL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CL
Colgate Palmolive Co
|
85.90 | 68.68B | 20.10B | 3.04B | 3.44B | 3.569 |
|
PG
Procter Gamble Co
|
148.31 | 347.41B | 85.26B | 16.53B | 14.85B | 6.7488 |
|
UL
Unilever Plc Adr
|
67.45 | 146.78B | 64.99B | 6.71B | 6.53B | 2.74 |
|
EL
Estee Lauder Cos Inc
|
116.72 | 41.94B | 14.42B | -930.00M | 1.05B | -2.5832 |
|
KVUE
Kenvue Inc
|
17.45 | 33.80B | 15.01B | 1.43B | 1.63B | 0.744 |
Colgate Palmolive Co Stock (CL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-26 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jan-07-26 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-11-25 | Downgrade | Argus | Buy → Hold |
| Dec-09-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-03-25 | Resumed | Piper Sandler | Neutral |
| Oct-28-24 | Downgrade | Stifel | Buy → Hold |
| Sep-24-24 | Initiated | Piper Sandler | Overweight |
| Sep-16-24 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Sep-09-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-26-24 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-23-24 | Initiated | TD Cowen | Buy |
| Jun-24-24 | Initiated | Exane BNP Paribas | Outperform |
| Mar-01-24 | Resumed | Goldman | Buy |
| Jan-29-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-23 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-13-23 | Initiated | Jefferies | Buy |
| Oct-16-23 | Upgrade | Stifel | Hold → Buy |
| Sep-22-23 | Initiated | HSBC Securities | Buy |
| Feb-17-23 | Initiated | Citigroup | Buy |
| Jan-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-22-22 | Initiated | Wolfe Research | Peer Perform |
| Oct-13-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-01-22 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| May-03-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Apr-08-22 | Initiated | Raymond James | Mkt Perform |
| Feb-02-22 | Upgrade | Bernstein | Underperform → Mkt Perform |
| Jan-31-22 | Reiterated | Citigroup | Neutral |
| Jan-31-22 | Reiterated | Credit Suisse | Outperform |
| Jan-31-22 | Reiterated | Deutsche Bank | Buy |
| Jan-31-22 | Reiterated | Morgan Stanley | Equal-Weight |
| Jan-31-22 | Reiterated | Wells Fargo | Underweight |
| Dec-16-21 | Initiated | Redburn | Neutral |
| Oct-05-21 | Resumed | BofA Securities | Neutral |
| Sep-20-21 | Upgrade | Deutsche Bank | Hold → Buy |
| Jun-24-21 | Initiated | UBS | Buy |
| Jun-09-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-01-21 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jan-28-21 | Downgrade | Stifel | Buy → Hold |
| Jan-26-21 | Upgrade | Berenberg | Sell → Hold |
| Jan-20-21 | Initiated | Bernstein | Underperform |
| Jan-04-21 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Dec-08-20 | Initiated | Wells Fargo | Underweight |
| Jul-22-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Mar-27-20 | Upgrade | Stifel | Hold → Buy |
| Mar-27-20 | Upgrade | SunTrust | Hold → Buy |
| Mar-23-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Mar-20-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Feb-03-20 | Upgrade | Atlantic Equities | Neutral → Overweight |
| Feb-03-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Dec-19-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-16-19 | Initiated | Berenberg | Sell |
| Apr-29-19 | Upgrade | JP Morgan | Underweight → Neutral |
| Mar-07-19 | Initiated | Credit Suisse | Underperform |
| Feb-11-19 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Jan-11-19 | Initiated | Evercore ISI | Outperform |
| Jan-09-19 | Upgrade | Goldman | Neutral → Buy |
| Oct-29-18 | Downgrade | JP Morgan | Neutral → Underweight |
| Oct-26-18 | Downgrade | SunTrust | Buy → Hold |
| Jul-30-18 | Downgrade | Macquarie | Outperform → Neutral |
| May-25-18 | Upgrade | Argus | Hold → Buy |
| Apr-30-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
View All
Colgate Palmolive Co Stock (CL) Latest News
Colgate-Palmolive, WHO Foundation partner - DrBicuspid.com
Is Colgate-Palmolive (CL) Offering A Fair Entry Point After Recent Share Price Rebound? - Yahoo Finance UK
Colgate-Palmolive’s Upcoming Earnings: A Key Test for Investor Sentiment - AD HOC NEWS
Is Colgate Palmolive (CL) Pricing Reflect Recent Gains Or Suggest Further Upside Potential - simplywall.st
Y Intercept Hong Kong Ltd Has $13.42 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive Company $CL Stake Raised by TrueMark Investments LLC - MarketBeat
Colgate-Palmolive Company $CL Shares Sold by Simplicity Wealth LLC - MarketBeat
Rakuten Investment Management Inc. Takes $2.34 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Deutsche Bank Adjusts Price Target on Colgate-Palmolive to $83 From $81, Maintains Hold Rating - marketscreener.com
Colgate-Palmolive (CL) Reports Next Week: What You Should Expect - Finviz
Colgate-Palmolive & WHO Foundation Partner for Oral Health - Sustainability Magazine
Palmolive Soap Review: Why This Everyday Hand Wash Suddenly Feels Like a Small Luxury - AD HOC NEWS
Colgate-Palmolive stock maintains Buy rating at UBS ahead of earnings - Investing.com Nigeria
How Colgate-Palmolive’s WHO Foundation Oral Health Push At Colgate-Palmolive (CL) Has Changed Its Investment Story - simplywall.st
Did Colgate-Palmolive’s (CL) WHO Oral Health Alliance Just Recast Its Sustainability Investment Narrative? - Yahoo Finance
Colgate-Palmolive and WHO Foundation Announce Global Partnership on Oral Health - 뉴스와이어
Ex-Dividend Reminder: Colgate-Palmolive, Lowe's Companies and CVS Health - Nasdaq
3.7 billion affected by oral disease; Colgate backs 4-year WHO campaign - Stock Titan
Colgate-Palmolive India Schedules Board Meeting for January 29, 2026 to Approve Q3FY26 Financial Results - scanx.trade
Barclays Raises Colgate (CL) Target to $83 but Stays Cautious on Fundamentals - Finviz
Market Trading Guide: Buy Ashok Leyland, Polycab India and 2 more stocks on Tuesday for up to 12% upside - The Economic Times
Campbell & CO Investment Adviser LLC Buys New Holdings in Colgate-Palmolive Company $CL - MarketBeat
The Truth About Colgate-Palmolive: Why Everyone Is Suddenly Watching This ‘Boring’ Stock - AD HOC NEWS
Colgate-Palmolive Co (CL) Stock Price, Trades & News - GuruFocus
JP Morgan Raises Price Target for Colgate-Palmolive (CL) to $93 - GuruFocus
Colgate-Palmolive (NYSE:CL) Price Target Raised to $93.00 at JPMorgan Chase & Co. - MarketBeat
Colgate-Palmolive to stream 2025 earnings call investors can replay - Stock Titan
Barclays Adjusts Price Target on Colgate-Palmolive to $83 From $80, Maintains Equalweight Rating - marketscreener.com
Household Products Stocks Q3 Teardown: Colgate-Palmolive (NYSE:CL) Vs The Rest - Finviz
Colgate-Palmolive Company $CL Stake Raised by Alliance Wealth Management Group - MarketBeat
Colgate-Palmolive flosses away dental care shadows to reveal 'the sweet truth' - Campaign India
$332M Colgate-Palmolive Pension Deal Nabs Final Nod - Law360
Colgate-Palmolive Cleared for $332 Million Pension Class Deal - Bloomberg Law News
Manning & Napier Advisors LLC Sells 35,021 Shares of Colgate-Palmolive Company $CL - MarketBeat
Palmolive Duschgel Review: The Surprisingly Affordable Shower Upgrade Everyone’s Sleeping On - AD HOC NEWS
UBS Maintains Colgate-Palmolive (CL) Rating and Raises Price Tar - GuruFocus
TD Cowen is Bullish on Colgate-Palmolive Company (CL) - Finviz
Colgate-Palmolive (NYSE:CL) Upgraded to Equal Weight at Wells Fargo & Company - MarketBeat
Ranking of most iconic U.S. companies includes 3 in Ohio - cleveland.com
TD Private Client Wealth LLC Has $2.93 Million Stock Position in Colgate-Palmolive Company $CL - MarketBeat
Is Colgate (CL) Turning Emerging-Market Social Impact Into a Durable Brand and Margin Advantage? - simplywall.st
Colgate-Palmolive’s Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - The Hindu
Wells Fargo Upgrades Colgate-Palmolive (CL) - Nasdaq
Analysts See Value Emerging in Colgate-Palmolive Shares - AD HOC NEWS
Demystifying Colgate-Palmolive: Insights From 13 Analyst Reviews - Benzinga
7 Best Beauty Stocks to Buy Right Now - Insider Monkey
Is Colgate's Cost Discipline Enough in a Softer Demand Cycle? - Nasdaq
Colgate-Palmolive emerges from difficult 2025 with a balanced risk/reward -- Wells Fargo (CL:NYSE) - Seeking Alpha
Colgate-Palmolive (CL): Wells Fargo Upgrades to Equal-Weight wit - GuruFocus
Liberty One Investment Management LLC Has $6.48 Million Position in Colgate-Palmolive Company $CL - MarketBeat
Colgate-Palmolive's Integrated CSR and ESG Initiatives Create an Impact on Health, Dignity and Community Well-Being - Business Standard
Colgate Palmolive Co Stock (CL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.34%
0.99%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):